Treatment with pyrrolidine dithiocarbamate improves proteinuria, oxidative stress, and glomerular hypertension in overload proteinuria

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 5, 2008, Pages

  Tapia, Edilia ^a   Sánchez González, Dolores J ^c   Medina Campos, Omar N ^e   Soto, Virgilia ^a   Ávila Casado, Carmen ^a   Martínez Martínez, Claudia M ^c   Johnson, Richard J ^b   Rodríguez Iturbe, Bernardo ^d   Pedraza Chaverrí, José ^e   Franco, Martha ^a   Sánchez Lozada, Laura Gabriela ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b UNIVERSITY OF FLORIDA   (United States)

^c Escuela Médico Militar   (Mexico)

^d UNIVERSIDAD DEL ZULIA   (Venezuela)

^e Universidad Nacional Autonoma de Mexico Facultad de Quimica   (Mexico)

Author keywords

Antioxidant enzymes; Inflammatory cell infiltration; Preglomerular arteriolopathy

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; ALBUMIN; BOVINE SERUM ALBUMIN; CATALASE; CD68 ANTIGEN; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; PYRROLIDINE DITHIOCARBAMATE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; SYNAPTOTAGMIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; GLOMERULUS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; MORPHOMETRICS; NEPHROTIC SYNDROME; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINURIA; RAT; RENOVASCULAR HYPERTENSION; URODYNAMICS;

EID: 57349162022     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90201.2008     Document Type: Article

References (53)

1. Alvarez V, Quiroz Y, Nava M, Pons H, Rodriguez-Iturbe B. Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells. Am J Physiol Renal Physiol 283: F1132-F1141, 2002.
2. Ardiles LG, Loyola F, Ehrenfeld P, Burgos ME, Flores CA, Valderrama G, Caorsi I, Egido J, Mezzano SA, Figueroa CD. Modulation of renal kallikrein by a high potassium diet in rats with intense proteinuria. Kidney Int 69: 53-59, 2006.
3. Barrera D, Maldonado PD, Medina-Campos ON, Hernandez-Pando R, Ibarra-Rubio ME, Pedraza-Chaverri J. Protective effect of SnCl2 on K2Cr2O7-induced nephrotoxicity in rats: the indispensability of HO-1 preinduction and lack of association with some antioxidant enzymes. Life Sci 73: 3027-3041, 2003.
4. Bautista-Garcia P, Sanchez-Lozada LG, Cristobal-Garcia M, Tapia E, Soto V, vila-Casado MC, Marquez-Velasco R, Bojalil R, Franco M, Herrera-Acosta J. Chronic inhibition of NOS-2 ameliorates renal injury, as well as COX-2 and TGF-beta 1 overexpression in 5/6 nephrectomized rats. Nephrol Dial Transplant 21: 3074-3081, 2006.
5. Baylis C, Deen WM, Myers BD, Brenner BM. Effects of some vasodilator drugs on transcapillary fluid exchange in renal cortex. Am J Physiol 230: 1148-1158, 1976.
6. Becker GJ, Hewitson TD. The role of tubulointerstitial injury in chronic renal failure. Curr Opin Nephrol Hypertens 9: 133-138, 2000.
7. Bohle A, Christ H, Grund KE, Mackensen S. The role of the interstitium of the renal cortex in renal disease. Contrib Nephrol 16: 109-114, 1979.
8. Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol Renal Fluid Electrolyte Physiol 249: F324-F337, 1985.
9. Chirino YI, Sanchez-Gonzalez DJ, Martinez-Martinez CM, Cruz C, Pedraza-Chaverri J. Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology 245: 18-23, 2008.
10. Chung KC, Park JH, Kim CH, Lee HW, Sato N, Uchiyama Y, Ahn YS. Novel biphasic effect of pyrrolidine dithiocarbamate on neuronal cell viability is mediated by the differential regulation of intracellular zinc and copper ion levels, NF-kappaB, and MAP kinases. J Neurosci Res 59: 117-125, 2000.
11. Cravedi P, Ruggenenti P, Remuzzi G. Intensified inhibition of renin-angiotensin system: a way to improve renal protection? Curr Hypertens Rep 9: 430-436, 2007.
12. Davidson WD, Sackner MA. Simplification of the anthrone method for the determination of inulin in clearance studies. J Lab Clin Med 62: 351-356, 1963.
13. Davies DJ, Messina A, Thumwood CM, Ryan GB. Glomerular podocytic injury in protein overload proteinuria. Pathology 17: 412-419, 1985.
14. Eddy AA. Interstitial nephritis induced by protein overload proteinuria. Am J Pathol 135: 719-733, 1989.
15. Eddy AA, Giachelli CM. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein overload proteinuria. Kidney Int 47: 1546-1557, 1995.
16. Franco M, Tapia E, Santamaria J, Zafra I, Garcia-Torres R, Gordon KL, Pons H, Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J. Renal cortical vasoconstriction contributes to development of salt-sensitive hypertension after angiotensin II exposure. J Am Soc Nephrol 12: 2263-2271, 2001.
17. Fujihara CK, Antunes GR, Mattar AL, Malheiros DM, Vieira JM Jr, Zatz R. Chronic inhibition of nuclear factor-κB attenuates renal injury in the 5/6 renal ablation model. Am J Physiol Renal Physiol 292: F92-F99, 2007.
18. Fujihara CK, Avancini Costa Malheiros DM, de Lourdes Noronha I, De Nucci G, Zatz R. Mycophenolate mofetil reduces renal injury in the chronic nitric oxide synthase inhibition model. Hypertension 37: 170-175, 2001.
19. Gomez-Garre D, Largo R, Tejera N, Fortes J, Manzarbeitia F, Egido J. Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin II and endothelin-1. Hypertension 37: 1171-1178, 2001.
20. Henry RJ, Sobel CH, Segalove M. Turbidimetric determination of proteins with sulfosalicylic and trichloroacetic acids. Proc Soc Exp Biol Med 92: 748-751, 1956.
21. Lemley KV. Glomerular size selectivity during protein overload in the rat. Am J Physiol Renal Fluid Electrolyte Physiol 264: F1046-F1051, 1993.
22. Min YK, Park JH, Chong SA, Kim YS, Ahn YS, Seo JT, Bae YS, Chung KC. Pyrrolidine dithiocarbamate-induced neuronal cell death is mediated by Akt, casein kinase 2, c-Jun N-terminal kinase, and IkappaB kinase in embryonic hippocampal progenitor cells. J Neurosci Res 71: 689-700, 2003.
23. Morigi M, Buelli S, Angioletti S, Zanchi C, Longaretti L, Zoja C, Galbusera M, Gastoldi S, Mundel P, Remuzzi G, Benigni A. In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies. Am J Pathol 166: 1309-1320, 2005.
24. 2 through a PKC-dependent pathway. J Am Soc Nephrol 13: 1179-1189, 2002.
25. Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, Theuer J, Breu V, Ganten D, Haller H, Luft FC. NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 35: 193-201, 2000.
26. Nurmi A, Goldsteins G, Narvainen J, Pihlaja R, Ahtoniemi T, Grohn O, Koistinaho J. Antioxidant pyrrolidine dithiocarbamate activates Akt-GSK signaling and is neuroprotective in neonatal hypoxia-ischemia. Free Radic Biol Med 40: 1776-1784, 2006.
27. Ofstad J, Iversen BM. Glomerular and tubular damage in normotensive and hypertensive rats. Am J Physiol Renal Physiol 288: F665-F672, 2005.
28. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424, 2007.
29. Park JK, Fiebeler A, Muller DN, Mervaala EM, Dechend R, bou-Rebyeh F, Luft FC, Haller H. Lacidipine inhibits adhesion molecule and oxidase expression independent of blood pressure reduction in angiotensin-induced vascular injury. Hypertension 39: 685-689, 2002.
30. Perico N, Codreanu I, Schieppati A, Remuzzi G. Pathophysiology of disease progression in proteinuric nephropathies. Kidney Int Suppl 94: S79-S82, 2005.
31. Rangan GK, Wang Y, Tay YC, Harris DC. Inhibition of nuclear factor-kappaB activation reduces cortical tubulointerstitial injury in proteinuric rats. Kidney Int 56: 118-134, 1999.
32. Rodriguez-Barbero A, L'Azou B, Cambar J, Lopez-Novoa JM. Potential use of isolated glomeruli and cultured mesangial cells as in vitro models to assess nephrotoxicity. Cell Biol Toxicol 16: 145-153, 2000.
33. Rodriguez-Iturbe B, Ferrebuz A, Vanegas V, Quiroz Y, Mezzano S, Vaziri ND. Early and sustained inhibition of nuclear factor-kappaB prevents hypertension in spontaneously hypertensive rats. J Pharmacol Exp Ther 315: 51-57, 2005.
34. Sanchez-Lozada LG, Tapia E, Jimenez A, Bautista P, Cristobal M, Nepomuceno T, Soto V, vila-Casado C, Nakagawa T, Johnson RJ, Herrera-Acosta J, Franco M. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 292: F423-F429, 2007.
35. Sanchez-Lozada LG, Tapia E, Johnson RJ, Rodriguez-Iturbe B, Herrera-Acosta J. Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation. Kidney Int Suppl 86: S9-S14, 2003.
36. Sanchez-Lozada LG, Tapia E, Santamaria J, vila-Casado C, Soto V, Nepomuceno T, Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 67: 237-247, 2005.
37. Sanchez-Lozada LG, Tapia E, Vila-Casado C, Soto V, Franco M, Santamaria J, Nakagawa T, Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J. Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 283: F1105-F1110, 2002.
38. Sawada H, Mitani Y, Maruyama J, Jiang BH, Ikeyama Y, Dida FA, Yamamoto H, Imanaka-Yoshida K, Shimpo H, Mizoguchi A, Maruyama K, Komada Y. A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats. Chest 132: 1265-1274, 2007.
39. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 175: 1181-1194, 1992.
40. Sohn WJ, Lee KW, Lee Y, Han JH, Choe YK, Kim DS, Kwon HJ. Pyrrolidine dithiocarbamate-induced macrophage inflammatory protein-2 gene expression is NF-kappaB-independent but c-Jun-dependent in macrophage cell line RAW 264.7. Mol Immunol 42: 1165-1175, 2005.
41. Takase O, Hirahashi J, Takayanagi A, Chikaraishi A, Marumo T, Ozawa Y, Hayashi M, Shimizu N, Saruta T. Gene transfer of truncated IkappaBalpha prevents tubulointerstitial injury. Kidney Int 63: 501-513, 2003.
42. Takase O, Marumo T, Imai N, Hirahashi J, Takayanagi A, Hishikawa K, Hayashi M, Shimizu N, Fujita T, Saruta T. NF-kappaB-dependent increase in intrarenal angiotensin II induced by proteinuria. Kidney Int 68: 464-473, 2005.
43. Tapia E, Franco M, Sanchez-Lozada LG, Soto V, Avila-Casado C, Santamaria J, Quiroz Y, Rodriguez-Iturbe B, Herrera-Acosta J. Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension. Kidney Int 63: 994-1002, 2003.
44. Theuer J, Dechend R, Muller DN, Park JK, Fiebeler A, Barta P, Ganten D, Haller H, Dietz R, Luft FC. Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats. BMC Cardiovasc Disord 2: 3, 2002.
45. Topping RJ, Jones MM. Optimal dithiocarbamate structure for immunomodulator action. Med Hypotheses 27: 55-57, 1988.
46. Viets JW, Deen WM, Troy JL, Brenner BM. Determination of serum protein concentration in nanoliter blood samples using fluorescamine or 9-phthalaldehyde. Anal Biochem 88: 513-521, 1978.
47. Vurek GG, Pegram SE. Fluorometric method for the determination of nanogram quantities of inulin. Ann Biochem Exp Med (Calcutta) 16: 409-419, 1966.
48. Weening JJ, Van Guldener C, Daha MR, Klar N, van der WA, Prins FA. The pathophysiology of protein overload proteinuria. Am J Pathol 129: 64-73, 1987.
49. Wilcox CS, Gutterman D. Focus on oxidative stress in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 288: H3-H6, 2005.
50. Yam-Canul P, Chirino YI, Sanchez-Gonzalez DJ, Martinez-Martinez CM, Cruz C, Villanueva C, Pedraza-Chaverri J. Nordihydroguaiaretic acid attenuates potassium dichromate-induced oxidative stress and nephrotoxicity. Food Chem Toxicol 46: 1089-1096, 2008.
51. Yoshioka T, Ichikawa I. Glomerular dysfunction induced by polymorphonuclear leukocyte-derived reactive oxygen species. Am J Physiol Renal Fluid Electrolyte Physiol 257: F53-F59, 1989.
52. Zoja C, Benigni A, Remuzzi G. Cellular responses to protein overload: key event in renal disease progression. Curr Opin Nephrol Hypertens 13: 31-37, 2004.
53. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 53: 1608-1615, 1998.